| Analysis | Metabolite Name | Measured Value | Units | Sex | Severity_Scale | Race | Ethnicity | hasSmokingBeforeCOVID-19 | Time |
|---|---|---|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.718366527 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.714929955 | log transformed data | Male | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.703879853 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.698678935 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.665769501 | log transformed data | Male | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.660277545 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.65236198 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.646075843 | log transformed data | Male | 2 | Other | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.640133466 | log transformed data | Female | 2 | Other | Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.63860482 | log transformed data | Male | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.634038072 | log transformed data | Male | 2 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.6311392 | log transformed data | Female | 2 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.624453634 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.60935583 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.59662444 | log transformed data | Female | 1 | Other | Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.589493069 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.584897506 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.58271261 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.579111454 | log transformed data | Male | 2 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.578716575 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.567940258 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.566725595 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.561923339 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.559558337 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.55504743 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.552810677 | log transformed data | Female | 2 | Other | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.545500729 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.543361023 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.542669384 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.535835385 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.52658866 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.526288547 | log transformed data | Male | 3 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.525087592 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.517715438 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.516244624 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.514533223 | log transformed data | Male | 2 | Other | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.512935424 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.51047796 | log transformed data | Female | 3 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.50983368 | log transformed data | Female | 1 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.508173628 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.50647627 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.502794286 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.502330622 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.490853344 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.489981922 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.484059558 | log transformed data | Female | 2 | White | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.479124472 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.478363707 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.476728984 | log transformed data | Female | 2 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.476728964 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.474589105 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.464054494 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.45961808 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.449770051 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.444741709 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.443053666 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.439860237 | log transformed data | Female | 3 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.439538941 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.438550937 | log transformed data | Male | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.437104712 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.436579622 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.43181057 | log transformed data | Male | 3 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.429726006 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.428388915 | log transformed data | Male | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.424199938 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.419335038 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.418242987 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.418200916 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.416291941 | log transformed data | Male | 1 | Other | Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.415880423 | log transformed data | Female | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.415358279 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.409042399 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.406922509 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.404264766 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.400445867 | log transformed data | Male | 1 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.398323093 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.393555305 | log transformed data | Male | 1 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.388948383 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.38639705 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.37842584 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.378371506 | log transformed data | Female | 2 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.377902437 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.375030993 | log transformed data | Male | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.372178508 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.370782995 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.369633584 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.366061094 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.36563666 | log transformed data | Female | 3 | Black | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.365471125 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.364309862 | log transformed data | Female | 3 | Other | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.362712663 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.361794207 | log transformed data | Female | 2 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.360806463 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.359763273 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.356953148 | log transformed data | Male | 3 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.356385282 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.350253071 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.349243881 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.343781839 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.342013405 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.341097868 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.339711557 | log transformed data | Male | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.339563082 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.337126654 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.335483723 | log transformed data | Female | 2 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.335477586 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.334432811 | log transformed data | Male | 1 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.330621227 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.329662018 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.32583191 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.322783873 | log transformed data | Male | 1 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.321389086 | log transformed data | Male | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.318388383 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.317432351 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.314660144 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.309149368 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.308607405 | log transformed data | Female | 1 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.304385991 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.301513873 | log transformed data | Male | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.300854725 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.30079219 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.300035423 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.296232202 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.295360333 | log transformed data | Female | 1 | White | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.291337752 | log transformed data | Female | 0 | White | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.285682434 | log transformed data | Female | 2 | White | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.285227403 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.284204702 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.283999488 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.283093948 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.28028551 | log transformed data | Male | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.279847531 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.277477063 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.273370869 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.273124096 | log transformed data | Male | 1 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.272987763 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.27231544 | log transformed data | Female | 2 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.271337214 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.268179664 | log transformed data | Male | 1 | Other | Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.26726994 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.266132546 | log transformed data | Male | 3 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.265793233 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.259122481 | log transformed data | Female | 2 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.257049568 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.255258908 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.249108287 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.249058709 | log transformed data | Female | 2 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.246276678 | log transformed data | Female | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.246079379 | log transformed data | Female | 2 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.242341135 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.240795195 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.240190441 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.238189391 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.234367875 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.233343873 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.232999579 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.229079165 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.228673009 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.226653203 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.226507514 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.222775433 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.222223266 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.2192102 | log transformed data | Female | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.217901291 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.215633791 | log transformed data | Male | 2 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.214722042 | log transformed data | Female | 3 | Other | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.21426606 | log transformed data | Male | 3 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.212821969 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.212031927 | log transformed data | Male | 2 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.211178072 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.210152379 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.209648588 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.208131322 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.206142469 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.204778249 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.204748354 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.202664607 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.202243488 | log transformed data | Male | 2 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.201801515 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.199914629 | log transformed data | Male | 2 | Other | Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.199565935 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.198146393 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.1972241 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.196236529 | log transformed data | Female | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.195814197 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.194165149 | log transformed data | Male | 0 | White | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.192399065 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.19230122 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.188997077 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.187998874 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.186701728 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.186672873 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.185975964 | log transformed data | Male | 1 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.18467591 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.182944585 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.181892787 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.181783904 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.180916724 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.180785647 | log transformed data | Female | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | -0.180675505 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Return to search page
